News | FDA | April 29, 2024

Elekta Instrument AB recalls disposable biopsy needle kit for Leksell Stereotactic System for possibly containing microscopic stainless steel debris on the inside of the biopsy needle

Elekta Instrument AB recalls disposable biopsy needle kit for Leksell Stereotactic System for possibly containing microscopic stainless steel febris on the inside of the biopsy needle

April 29, 2024 — The U.S. Food and Drug Administration (FDA) announced Elekta Instrument AB is recalling Disposable Biopsy Needles (911933) from one batch (837838839) which can contain some microscopic stainless steel debris on the inside of the biopsy needle. The presence of debris in biopsy samples can hinder examination and delay the process. Moreover, there's a risk of debris being deposited in the brain, which could affect future MRI scans, potentially rendering them useless or unobtainable.

The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death.

Recalled Product

  • Product Names: Disposable Biopsy Needles (911933)
  • Product Codes: HAW
  • Lot Number: 837838839
  • Distribution Dates: August 29, 2023 to January 5, 2024
  • Devices Recalled in the U.S.: 10
  • Date Initiated by Firm: March 15, 2024

Device Use

The Leksell Stereotactic System helps doctors locate and diagnose brain disorders. The Disposable Biopsy Needle Kit is used in neurosurgery for precise brain tissue sampling. It's designed for use with the Leksell Stereotactic System, allowing surgeons to obtain tissue samples accurately and minimally invasively.

Reason for Recall

Elekta Instrument AB is recalling Disposable Biopsy Needles (911933) from one batch (837838839) which can contain some microscopic stainless steel debris on the inside of the biopsy needle. The material in the debris is stainless steel, the same material as the biopsy needle.

If debris on the inside of the biopsy needle comes loose, it may appear in the biopsy sample and delay or make examination difficult. There is also a potential risk of debris being deposited in the brain. The long term functional consequences of such particles in the brain are unknown. If this occurs, the metallic debris could cause future MRI scans of the brain to be useless or even unable to be obtained. This is a serious negative consequence in a patient with a brain tumor who will require brain MRI surveillance scans for life, with no alternative available.

There have been no reported injuries and no reports of death associated with this issue.

Who May be Affected

  • Health care professionals, specifically specialists in brain disorders, who use the Disposable Biopsy Needle Kit and Leksell Stereotactic System
  • People receiving care using the Disposable Biopsy Needle Kit and Leksell Stereotactic System

What to Do

On March 15, 2024, Elekta sent all affected customers an Urgent Recall Notification.

The letter requested customers to:

  • Remove and dispose all Disposable Biopsy Needles (911933) from batch 837838839.
    • Contact the local Elekta representative for ordering replacement needle kits.
  • Post this notice in a place accessible to all users and advise appropriate personnel.
  • Complete the included Acknowledge Form and return it to Elekta.

Contact Information

Customers in the U.S. with questions about this recall should contact Elekta Instrument AB at (855) 693-5358.

Additional Resources

How do I report a problem?

Health care professionals and consumers may report adverse reactions or quality problems they experienced using these devices to MedWatch: The FDA Safety Information and Adverse Event Reporting Program using an online form, regular mail, or FAX.


Related Content

News | Breast Imaging

June 2, 2025 — Clairity, Inc., a digital health innovator advancing AI-driven healthcare solutions, has received U.S ...

Time June 02, 2025
arrow
News | Magnetic Resonance Imaging (MRI)

Hyperfine, Inc., producer of the world’s first FDA-cleared AI-powered portable MRI system for the brain — the Swoop ...

Time May 29, 2025
arrow
News | Pediatric Imaging

May 13, 2025-- GE HealthCare recently announced the U.S. Food and Drug Administration (FDA) has approved a pediatric ...

Time May 20, 2025
arrow
News | Cardiac Imaging

May 19, 2025 - Arineta, a provider of cardiovascular imaging solutions, recently announced that its SpotLight Duo ...

Time May 19, 2025
arrow
News | Computed Tomography (CT)

May 15, 2025 — GE HealthCare has launched CleaRecon DL, technology powered by a deep-learning algorithm, to improve the ...

Time May 15, 2025
arrow
News | Radiation Therapy

May 14, 2025 — Siemens Healthineers is investing $150 million in new projects to expand production, create jobs and ...

Time May 15, 2025
arrow
News | Magnetic Resonance Imaging (MRI)

May 12, 2025 — GE HealthCare recently unveiled Signa Sprint, an FDA 510(k) pending[1] ultra-premium wide bore 1.5T high ...

Time May 12, 2025
arrow
News | Nuclear Imaging

May 5, 2025 — GE HealthCare recently announced that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance ...

Time May 06, 2025
arrow
News | Radiation Oncology

May 2, 2025 — GE HealthCare has announced an intended expansion of its radiation oncology portfolio as well as the ...

Time May 03, 2025
arrow
News | Radiology Education

April 21, 2025 — On June 20, the American Society of Radiologic Technologists (ASRT) will award Life Member status to ...

Time April 21, 2025
arrow
Subscribe Now